1.
Makowska K, Panuciak K, Mastalerczyk A, Nowicka E, Obel M, Czyżak K, et al. Chimeric antigen receptor T-cell as a significant player in the innovative treatment of hematological cancers. J Educ Health Sport [Internet]. 2023 Jan. 26 [cited 2025 Jun. 28];13(3):134-9. Available from: https://apcz.umk.pl/JEHS/article/view/41589